NCT05770869

mHealth ALIBIRD: A Digital Health Care Model

mHealth ALIBIRD: A Digital Health Care Model (Analysis of the Applicability of an m-Health Platform and Its Impact on the Follow-up of Patients With Cancer: Pilot Study in a Sample of Patients With Advanced Non-small Cell Carcinoma)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The aim of this pilot study was to evaluate the feasibility and acceptability of the ALIBIRD platform, a new mobile health (mHealth) application prototype design for personalized and remote support on the follow-up of cancer patients. The ALIBIRD platform is a mHealth intervention that tracks PROs, improving symptom control and allowing real-time feedback, and provides personalized recommendations and educational content, promoting empowerment and encourage healthy lifestyle behaviors in patients with thoracic neoplasms in active treatment.

Detailed description

The investigators have developed an innovative mHealth platform that provides personalized recommendations based on Patient Reported Outcomes (PROs) records and the study of patient´s nutrigenomics and gut microbiome. The usability of the ALIBIRD mHealth platform prototype is being tested in a 28-week pilot study carried out at Infanta Sofía Hospital. A small group of stage IV thoracic neoplasms patients (n=20) were asked to participate. All the participants gave informed consent.

Conditions

• Thoracic Neoplasms

Interventions

Type	Name	Description
DEVICE	ALIBIRD mHealth platform	Use of a mHealth platform to follow-up and empower cancer patients in the self-management of their own health.

Timeline

• Start date: 2021-11-05
• Primary completion: 2022-10-28
• Completion: 2022-10-28
• First posted: 2023-03-16
• Last updated: 2023-10-18

Locations

1 site across 1 country: Spain